The Business Research Company’s global market reports are now updated with the latest market sizing
Read More
The global racecadotril market to reach $4.9 billion by 2030 at 7.3% CAGR, driven by rising incidence of diarrhea.
Read More
Quit smoking drugs market to reach $90.73 billion by 2030 at 15.5% CAGR, driven by growing prevalence of smoking addiction.
Read More
Quinolones market to reach $66.44 billion by 2030 at 5.1% CAGR, driven by increasing danger of antimicrobial resistance.
Read More
The global quinine sulfate market to reach $3.81 billion by 2030 at 8.0% CAGR, driven by growing malaria incidence.
Read More
The global quinine market to reach $3.76 billion by 2030 at 8.8% CAGR, driven by rising prevalence of malaria.
Read More
Quadrivalent market to reach $15.37 billion by 2030 at 10.1% CAGR, driven by rising immunization coverage across the world.
Read More
Purvalanol a (cdk inhibitor) market to reach $1.01 billion by 2030 at 9.6% CAGR, driven by increasing prevalence of cancer.
Read More
Purine analogues drugs market to reach $27.44 billion by 2030 at 11.0% CAGR, driven by rising prevalence of hematologic malignancies.
Read More
Pulmonary or respiratory drug delivery market to reach $114.23 billion by 2030 at 8.6% CAGR, driven by increasing prevalence of pneumonia.
Read More
Pulmonary drugs market to reach $74.14 billion by 2030 at 5.4% CAGR, driven by increasing prevalence of respiratory diseases.
Read More